200 related articles for article (PubMed ID: 22514694)
21. 3,3'-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway.
Li XJ; Park ES; Park MH; Kim SM
Oncol Rep; 2013 Nov; 30(5):2419-26. PubMed ID: 24008339
[TBL] [Abstract][Full Text] [Related]
22. Differential modulation of dibenzo[def,p]chrysene transplacental carcinogenesis: maternal diets rich in indole-3-carbinol versus sulforaphane.
Shorey LE; Madeen EP; Atwell LL; Ho E; Löhr CV; Pereira CB; Dashwood RH; Williams DE
Toxicol Appl Pharmacol; 2013 Jul; 270(1):60-9. PubMed ID: 23566957
[TBL] [Abstract][Full Text] [Related]
23. The dietary phytochemical 3,3'-diindolylmethane induces G2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-κB, MAPK, and p53 signaling.
Weng JR; Bai LY; Chiu CF; Wang YC; Tsai MH
Chem Biol Interact; 2012 Feb; 195(3):224-30. PubMed ID: 22290291
[TBL] [Abstract][Full Text] [Related]
24. Senescent stromal cell-induced divergence and therapeutic resistance in T cell acute lymphoblastic leukemia/lymphoma.
Habiel DM; Krepostman N; Lilly M; Cavassani K; Coelho AL; Shibata T; Elenitoba-Johnson K; Hogaboam CM
Oncotarget; 2016 Dec; 7(50):83514-83529. PubMed ID: 27835864
[TBL] [Abstract][Full Text] [Related]
25. 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression.
Hong C; Kim HA; Firestone GL; Bjeldanes LF
Carcinogenesis; 2002 Aug; 23(8):1297-305. PubMed ID: 12151347
[TBL] [Abstract][Full Text] [Related]
26. Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro.
Sun S; Han J; Ralph WM; Chandrasekaran A; Liu K; Auborn KJ; Carter TH
Cell Stress Chaperones; 2004 Mar; 9(1):76-87. PubMed ID: 15270080
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.
Rahman KM; Ali S; Aboukameel A; Sarkar SH; Wang Z; Philip PA; Sakr WA; Raz A
Mol Cancer Ther; 2007 Oct; 6(10):2757-65. PubMed ID: 17913854
[TBL] [Abstract][Full Text] [Related]
28. 3,3'-Diindolylmethane exhibits antileukemic activity in vitro and in vivo through a Akt-dependent process.
Gao N; Cheng S; Budhraja A; Liu EH; Chen J; Chen D; Yang Z; Luo J; Shi X; Zhang Z
PLoS One; 2012; 7(2):e31783. PubMed ID: 22363731
[TBL] [Abstract][Full Text] [Related]
29. 3-(2-Bromoethyl)-indole inhibits the growth of cancer cells and NF-κB activation.
Fadlalla K; Elgendy R; Gilbreath E; Pondugula SR; Yehualaeshet T; Mansour M; Serbessa T; Manne U; Samuel T
Oncol Rep; 2015 Jul; 34(1):495-503. PubMed ID: 26063116
[TBL] [Abstract][Full Text] [Related]
30. 3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status.
Vivar OI; Lin CL; Firestone GL; Bjeldanes LF
Biochem Pharmacol; 2009 Sep; 78(5):469-76. PubMed ID: 19433067
[TBL] [Abstract][Full Text] [Related]
31. Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia.
Lonetti A; Antunes IL; Chiarini F; Orsini E; Buontempo F; Ricci F; Tazzari PL; Pagliaro P; Melchionda F; Pession A; Bertaina A; Locatelli F; McCubrey JA; Barata JT; Martelli AM
Leukemia; 2014 Jun; 28(6):1196-206. PubMed ID: 24310736
[TBL] [Abstract][Full Text] [Related]
32. Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates.
Saw CL; Cintrón M; Wu TY; Guo Y; Huang Y; Jeong WS; Kong AN
Biopharm Drug Dispos; 2011 Jul; 32(5):289-300. PubMed ID: 21656528
[TBL] [Abstract][Full Text] [Related]
33. YM155 induces apoptosis in p53-deficient T-acute lymphoblastic leukemia cells independent of survivin inhibition.
Sales L; de Sousa GR; Ferreira-Silva GÁ; Castro-Gamero AM; Ionta M; de Oliveira JC
Anticancer Drugs; 2017 Mar; 28(3):298-306. PubMed ID: 27930382
[TBL] [Abstract][Full Text] [Related]
34. Treatment of human T-cell acute lymphoblastic leukemia cells with CFTR inhibitor CFTRinh-172.
Liu M; Liao H; Chen Y; Lin Z; Liu Y; Zhang X; Chan HC; Sun H
Leuk Res; 2019 Nov; 86():106225. PubMed ID: 31541940
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells.
Rahman KW; Sarkar FH
Cancer Res; 2005 Jan; 65(1):364-71. PubMed ID: 15665315
[TBL] [Abstract][Full Text] [Related]
37. 3,3'-Diindolylmethane inhibits prostate cancer development in the transgenic adenocarcinoma mouse prostate model.
Cho HJ; Park SY; Kim EJ; Kim JK; Park JH
Mol Carcinog; 2011 Feb; 50(2):100-12. PubMed ID: 21229607
[TBL] [Abstract][Full Text] [Related]
38. Antiangiogenic effects of indole-3-carbinol and 3,3'-diindolylmethane are associated with their differential regulation of ERK1/2 and Akt in tube-forming HUVEC.
Kunimasa K; Kobayashi T; Kaji K; Ohta T
J Nutr; 2010 Jan; 140(1):1-6. PubMed ID: 19889811
[TBL] [Abstract][Full Text] [Related]
39. B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer.
Singh-Gupta V; Banerjee S; Yunker CK; Rakowski JT; Joiner MC; Konski AA; Sarkar FH; Hillman GG
Cancer Lett; 2012 May; 318(1):86-92. PubMed ID: 22155105
[TBL] [Abstract][Full Text] [Related]
40. Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.
Moiseeva EP; Almeida GM; Jones GD; Manson MM
Mol Cancer Ther; 2007 Nov; 6(11):3071-9. PubMed ID: 18025290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
